NEW YORK(GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its fiscal second quarter revenues were down almost 3 percent year over year. 

For the three months ended April 30, the firm reported $963 million in revenues, down from $988 million in Q2 2014, and missing the average analysts' estimate of $983.9 million. Excluding currency effects, revenues were up 4 percent year over year, Agilent said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.